Information contained herein is subject to completion or amendment. A registration statement relating to these securities has been filed with the SEC. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This prospectus shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
SUBJECT TO COMPLETION, DATED JULY 26, 2024
PRELIMINARY PROSPECTUS
Up to 6,849,315 Shares of Class A Common Stock
Up to 6,849,315 Pre-Funded Warrants
Up to 6,849,315 Common Warrants
Up to 13,698,630 Shares of Class A Common Stock Underlying Pre-Funded Warrants and Common Warrants
We are offering (i) 6,849,315 shares of Class A common stock of Volato Group, Inc. (the “Common Stock”) and (ii) Common Warrants to purchase 6,849,315 shares of common stock (“Common Warrants”), at an exercise price of $0.55 per share (representing 100% of the assumed public offering price per share of Common Stock to be sold in this offering), on a best-efforts basis. The Common Warrants will expire on the fifth anniversary of the original issuance date. We are offering the Common Stock and Common Warrants at an assumed purchase price of $0.55 per share, which is equal to the closing price of our common stock on the NYSE American on July 11, 2024.
The actual public offering price will be determined between us, A.G.P./Alliance Global Partners (“A.G.P.”), Roth Capital Partners, LLC (“Roth” and, together with A.G.P., whom we refer to herein as the “placement agent”) and the investors in the offering, and may be at a discount to the current market price of our common stock. Therefore, the assumed public offering price used throughout this prospectus may not be indicative of the final offering price.
We are also offering 6,849,315 pre-funded warrants, (“Pre-Funded Warrants”) to purchase up to 6,849,315 shares of Common Stock. We are offering to certain purchasers whose purchase of Common Stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% of our outstanding shares of Common Stock immediately following the consummation of this offering, the opportunity to purchase, if any purchaser so chooses, Pre-Funded Warrants, in lieu of shares of Common Stock that would otherwise result in such purchaser's beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding shares of Common Stock. The purchase price of each Pre-Funded Warrant is $0.5499 (which is equal to the assumed public offering price per share of Common Stock to be sold in this offering minus $0.0001, the exercise price per share of Common Stock of each Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. For each Pre-Funded Warrant we sell, the number of shares of Common Stock we are offering will be decreased on a one-for-one basis.
Because we will issue a Common Warrant for each share of Common Stock and for each Pre-Funded Warrant sold in this offering, the number of Common Warrants sold in this offering will not change as a result of a change in the mix of shares of Common Stock and Pre-Funded Warrants sold.
Each Pre-Funded Warrant may be exercised, immediately in cash and from time to time thereafter.
Our shares of Common Stock, Pre-Funded Warrants and Common Warrants can only be purchased together in this offering, but will be issued separately. Up to 13,698,630 shares of Common Stock issuable from time to time upon exercise of the Pre-Funded Warrants and Common Warrants are also being offered by this prospectus. These securities are being sold in this offering to certain purchasers under a securities purchase agreement dated July , 2024 between us and the purchasers.
Our shares of Common Stock are listed on the NYSE American under the symbol “SOAR.” On July 22, 2024, the last reported sale price of our shares of Common Stock on the NYSE American was $0.48 per share.
As stated above, the public offering price for our securities in this offering will be determined at the time of pricing, and may be at a discount to the then current market price. The assumed public offering price used throughout this prospectus may not be indicative of the final offering price. The final public offering price will be determined through negotiation between us and investors based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present operating results, the previous experience of our executive officers and the general condition of the securities markets at the time of this offering. There is no established public trading market for the Common Warrants and we do not expect markets to develop. Without an active trading market, the liquidity of the warrants will be limited. In addition, we do not intend to list the Pre-Funded Warrants or the Common Warrants on the NYSE American, any other national securities exchange or any other trading system.
We have retained the placement agent to act as our sole placement agent in connection with the securities offered by this prospectus. The placement agent is not purchasing or selling any of these securities nor is it required to sell any specific number or dollar amount of securities, but has agreed to use its reasonable best efforts to sell the securities offered by this prospectus. We may not sell all of the securities in this offering. We have agreed to pay the placement agent the placement agent fees set forth in the table below.
There is no minimum number of securities or minimum aggregate amount of proceeds for this offering to close. We expect this offering to be completed not later than two business days following the commencement of this offering and we will deliver all securities to be issued in connection with this offering delivery versus payment (“DVP”) /receipt versus payment (“RVP”) upon receipt of investor funds received by us. Accordingly, neither we nor the placement agent have made any arrangements to place investor funds in an escrow account or trust account since the placement agent will not receive investor funds in connection with the sale of the securities offered hereunder.
We are an “emerging growth company,” as that term is defined under the federal securities laws, and a “smaller reporting company” and, as such, are subject to certain reduced public company reporting requirements. See “Prospectus Summary—Implications of Being an Emerging Growth Company and a Smaller Reporting Company.”
Public offering price(1) | | | $ | | | | | | |
Placement Agent Fees(2) | | | $ | | | | | | |
Proceeds to us, before expenses(3) | | | $ | | | | | | |
(1)
| The public offering price is $ per share of common stock and $ per pre-funded warrant. |
(2)
| Represents a cash fee equal to seven percent (7%) of the aggregate purchase price paid by investors in this offering up to $15,000,000 and, a cash fee equal to six percent (6%) of the aggregate purchase price paid by investors above $15,000,000. Notwithstanding the foregoing, we and the placement agent, have agreed that for certain identified investors to a cash fee equal to three and a half percent (3.5%) of the aggregate purchase price paid by such investors in this offering up to $15,000,000 and, a cash fee equal to three percent (3%) of the aggregate purchase price paid by such investors above $15,000,000. We have also agreed to reimburse the placement agent for its accountable offering-related legal expenses in an amount up to $125,000 and pay the placement agent a non-accountable expense allowance of $25,000. See “Plan of Distribution” beginning on page 103 of this prospectus for a description of the compensation to be received by the placement agent. |
(3)
| Does not include proceeds from the exercise of the warrants in cash, if any. |
Investing in our securities involves a high degree of risk. See the “
Risk Factors” section beginning on page
11 of this prospectus.
Neither the Securities and Exchange Commission, or the SEC, nor any state securities commission has approved or disapproved of the securities to be issued under this prospectus or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Co-Placement Agents
A.G.P. | | | Roth Capital Partners |
The date of this prospectus is , 2024.